In Brief: Sen. Ron Wyden (D-Ore.)
This article was originally published in The Gray Sheet
Executive Summary
Sen. Ron Wyden (D-Ore.): Named to Senate committees on Environment, Commerce, Budget and Aging April 1. Republicans added to these committees to maintain party ratios are Sens. Robert Bennett (Utah) to Environment and Public Works; Spencer Abraham (Mich.) to Commerce; Rod Grams (Minn.) to Budget; and John Warner (Va.) to the Special Committee on Aging. Wyden is said to have been refused a seat on Labor and Human Resources due to Ranking Democratic Sen. Edward Kennedy's (Mass.) concern over allowing conservative Republican Sen. Launch Faircloth (R-N.C.) to join the committee to maintain party balance. Wyden was sworn into the Senate in February, following his Jan. 30 victory in a special election to replace departing Republican Sen. Bob Packwood ("The Gray Sheet" Feb. 5, p. 11)...
You may also be interested in...
Entries Begin To Roll In For 2024 Industry Awards
Entries have now begun rolling in for the Global Generics & Biosimilars Awards, which returns to Milan this October, Free to enter and attend, the ceremony recognizes the top achievements across the generics, biosimilars and value added medicines industries.
‘I Would Love To Have All The Biologic Assets’ – Formycon’s Glombitza Sets Out Portfolio Approach
In the second part of an exclusive interview, Formycon CEO Stefan Glombitza talks to Generics Bulletin about key regulatory developments in Europe and the US, the firm’s portfolio selection strategy, and upcoming milestones on the horizon.
First Off The Blocks, Fresenius Launches US Tocilizumab Biosimilar
Fresenius Kabi has kicked off competition to Genentech’s Actemra in the US, launching its Tyenne biosimilar version of tocilizumab.